Aussie tech startup acquired by Pfizer for $179 million after developing an app that can ‘hear’ COVID-19 Health Emma Elsworthy 28 September 2022 ASX-listed ResApp developed a smartphone application that studies showed could identify a COVID-19 infection from a person's cough.
